Cargando…

Increased Matrix Metalloproteinases in Cerebrospinal Fluids of Patients With Major Depressive Disorder and Schizophrenia

BACKGROUND: Chronic inflammation of the brain has a pivotal role in the pathophysiology of major depressive disorder (MDD) and schizophrenia (SCZ). Matrix metalloproteinases (MMPs) are extracellular proteases involved in pro-inflammatory processes and interact with interleukin-6, which is increased...

Descripción completa

Detalles Bibliográficos
Autores principales:	Omori, Wataru, Hattori, Kotaro, Kajitani, Naoto, Okada-Tsuchioka, Mami, Boku, Shuken, Kunugi, Hiroshi, Okamoto, Yasumasa, Takebayashi, Minoru
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2020
Materias:	Regular Research Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7745248/ https://www.ncbi.nlm.nih.gov/pubmed/32671384 http://dx.doi.org/10.1093/ijnp/pyaa049

Ejemplares similares

Reduced Cerebrospinal Fluid Levels of Lysophosphatidic Acid Docosahexaenoic Acid in Patients With Major Depressive Disorder and Schizophrenia
por: Omori, Wataru, et al.
Publicado: (2021)

Shared preventive factors associated with relapse after a response to electroconvulsive therapy in four major psychiatric disorders
por: Omori, Wataru, et al.
Publicado: (2019)

Reduced Serum and Cerebrospinal Fluid Levels of Autotaxin in Major Depressive Disorder
por: Itagaki, Kei, et al.
Publicado: (2019)

Antidepressant amitriptyline‐induced matrix metalloproteinase‐9 activation is mediated by Src family tyrosine kinase, which leads to glial cell line‐derived neurotrophic factor mRNA expression in rat astroglial cells
por: Abe, Hiromi, et al.
Publicado: (2019)

Serum levels of high mobility group box‐1 protein (HMGB1) and soluble receptors of advanced glycation end‐products (RAGE) in depressed patients treated with electroconvulsive therapy
por: Abe, Hiromi, et al.
Publicado: (2023)

Altered Serum Levels of Matrix Metalloproteinase-2, -9 in Response to Electroconvulsive Therapy for Mood Disorders
por: Shibasaki, Chiyo, et al.
Publicado: (2016)

Possible Association between Serum Matrix Metalloproteinase-9 (MMP-9) Levels and Relapse in Depressed Patients following Electroconvulsive Therapy (ECT)
por: Shibasaki, Chiyo, et al.
Publicado: (2017)

PS159. Altered serum levels of matrix metalloproteinase-2, -9 in response to electroconvulsive therapy for mood disorders.
por: Shibasaki, Chiyo, et al.
Publicado: (2016)

Decreased serum levels of thrombospondin‐1 in female depressed patients
por: Okada‐Tsuchioka, Mami, et al.
Publicado: (2019)

PS127. Antidepressant amitriptyline activates matrix metalloproteinase in astroglial cells: involvement in glial cell line-derived neurotrophic factor expression.
por: Abe, Hiromi, et al.
Publicado: (2016)

PS158. Factors associated with relapse after a response to electroconvulsive therapy in unipolar versus bipolar depression
por: Itagake, Kei, et al.
Publicado: (2016)

Tricyclic Antidepressant Amitriptyline Indirectly Increases the Proliferation of Adult Dentate Gyrus-Derived Neural Precursors: An Involvement of Astrocytes
por: Boku, Shuken, et al.
Publicado: (2013)

Antidepressant Acts on Astrocytes Leading to an Increase in the Expression of Neurotrophic/Growth Factors: Differential Regulation of FGF-2 by Noradrenaline
por: Kajitani, Naoto, et al.
Publicado: (2012)

Spectrum of matrix metalloproteinase expression in primary and metastatic colon cancer: relationship to the tissuenhibitors of metalloproteinases and membrane type-1-matrix metalloproteinase
por: Collins, H M, et al.
Publicado: (2001)

Impact of age on the cerebrospinal fluid spaces: high-convexity and medial subarachnoid spaces decrease with age
por: Hidaka, Yosuke, et al.
Publicado: (2022)

Collagenolytic and gelatinolytic matrix metalloproteinases and their inhibitors in basal cell carcinoma of skin: comparison with normal skin
por: Varani, J, et al.
Publicado: (2000)

Late-onset attention-deficit/hyperactivity disorder as a differential diagnosis of dementia: a case report
por: Sasaki, Hiroyuki, et al.
Publicado: (2020)

Late-manifestation of attention-deficit/hyperactivity disorder in older adults: an observational study
por: Sasaki, Hiroyuki, et al.
Publicado: (2022)

PM539. Evaluation of plasma and cerebrospinal fluid G72 protein levels and their correlations with psychiatric symptoms in schizophrenia and major depression
por: Ishiwata-Matsushima, Sayuri, et al.
Publicado: (2016)

Maintenance of the Extracellular Matrix in Rat Anterior Pituitary Gland: Identification of Cells Expressing Tissue Inhibitors of Metalloproteinases
por: Azuma, Morio, et al.
Publicado: (2015)

Matrix metalloproteinases in human melanoma cell lines and xenografts: increased expression of activated matrix metalloproteinase-2 (MMP-2) correlates with melanoma progression
por: Hofmann, U B, et al.
Publicado: (1999)

Editorial: Integrating molecular research into clinical psychiatry: An application to schizophrenia and mood disorders
por: Kanazawa, Tetsufumi, et al.
Publicado: (2023)

Cerebrospinal fluid cytokines, matrix metalloproteinases, HIV, and tuberculous meningitis
por: Tin, Sim Sai, et al.
Publicado: (2015)

A case report: Clozapine‐induced leukopenia and neutropenia after mRNA COVID‐19 vaccination
por: Imai, Tomoyuki, et al.
Publicado: (2022)

Immunohistochemical detection of membrane-type-1-matrix metalloproteinase in colorectal carcinoma
por: Kikuchi, R, et al.
Publicado: (2000)

Rat tail static compression model mimics extracellular matrix metabolic imbalances of matrix metalloproteinases, aggrecanases, and tissue inhibitors of metalloproteinases in intervertebral disc degeneration
por: Yurube, Takashi, et al.
Publicado: (2012)

Increased apolipoprotein E and decreased TNF‐α in the cerebrospinal fluid of nondemented APOE‐ε4 carriers
por: Sasayama, Daimei, et al.
Publicado: (2020)

Expression of matrix metalloproteinase-1, -2 and -3 in squamous cell carcinoma and actinic keratosis
por: Tsukifuji, R, et al.
Publicado: (1999)

The effects of exogenous growth factors on matrix metalloproteinase secretion by human brain tumour cells
por: Rooprai, H K, et al.
Publicado: (2000)

Matrix Metalloproteinase-2 Activated by Ultraviolet-B Degrades Human Ciliary Zonules In Vitro
por: Shiroto, Yuki, et al.
Publicado: (2021)

Lysophosphatidic acid levels in cerebrospinal fluid and plasma samples in patients with major depressive disorder
por: Gotoh, Leo, et al.
Publicado: (2019)

Dexamethasone, Cerebrospinal Fluid Matrix Metalloproteinase Concentrations and Clinical Outcomes in Tuberculous Meningitis
por: Green, Justin A., et al.
Publicado: (2009)

Dynamics of cerebrospinal fluid levels of matrix metalloproteinases in human traumatic brain injury
por: Minta, Karolina, et al.
Publicado: (2020)

PS238. Altered balance between monoamine metabolites in human cerebrospinal fluid with major depressive disorder.
por: Yoon, Hyung Shin, et al.
Publicado: (2016)

Investigation of chromosome Y loss in men with schizophrenia
por: Hirata, Takashi, et al.
Publicado: (2018)

Relationship between Performance on the Mini-Mental State Examination Sub-Items and Activities of Daily Living in Patients with Alzheimer’s Disease
por: Han, Gwanghee, et al.
Publicado: (2020)

Matrix metalloproteinases (MMPs) in fresh human prostate tumour tissue and organ-cultured prostate tissue: Levels of collagenolytic and gelatinolytic MMPs are low, variable and different in fresh tissue versus organ-cultured tissue
por: Varani, J, et al.
Publicado: (2001)

PM311. Possible role of CDH13 in nicotine dependence: Investigations on mouse neural progenitors and schizophrenia patients
por: Otsuka, Ikuo, et al.
Publicado: (2016)

Overexpression of matrix-metalloproteinase-9 in human breast cancer: a potential favourable indicator in node-negativeatients
por: Scorilas, A, et al.
Publicado: (2001)

Influence of angiogenetic factors and matrix metalloproteinases upon tumour progression in non-small-cell lung cancer
por: Shou, Y, et al.
Publicado: (2001)

Cannot write session to /tmp/vufind_sessions/sess_ct1jav9pk3pn324vvrsr6dc8pc